What question did this study set out to answer?

The aim is to evaluate whether the proposed Single National Formulary addresses the ongoing issues of treatment equity and timely access to medicines.

July 9, 2026Open Access

Single National Formulary: solution or distraction?

Key Points

The aim is to evaluate whether the proposed Single National Formulary addresses the ongoing issues of treatment equity and timely access to medicines.
Evaluation of the UK Government's 10-Year Health Plan for England regarding the SNF.
Assessment of concerns from NHS teams and industry stakeholders about the SNF.
The SNF may not solve the underlying issues of equitable treatment and timely access to cost-effective medicines.
Concerns have been raised from both local NHS teams and the pharmaceutical industry regarding the SNF’s implementation.

Abstract

The UK Government's 10-Year Health Plan for England identifies a problem: patients do not consistently receive rapid and equitable treatment with cost-effective medicines. 1However, the proposed Single National Formulary (SNF) risks repeating past mistakes by attempting to solve the wrong problems and is already drawing concerns from local National Health Service (NHS) teams and industry alike. 2

Ask AI

Helpful

Bookmark

View Full Paper